Supreme Court rejects Purdue Pharma $6 billion opioid settlement

Published



The Supreme Court on Thursday rejected Purdue Pharma’s proposed $6 billion bankruptcy settlement, holding that U.S. bankruptcy law did not allow the Sackler family to be released from additional liability.

A 5-4 majority opinion by Justice Neil Gorsuch sided with the Biden administration‘s argument that Purdue Pharma’s settlement is an abuse of bankruptcy protections meant for debtors in financial distress, not for the wealthy family owners of the multibillion-dollar opioid company, who withdrew $11 billion from Purdue Pharma before agreeing to contribute $6 billion to its opioid settlement.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.